The blood-brain barrier in neuroinflammatory diseases

Pharmacological Reviews

Volumn 49, Issue 2, 1997, Pages 143-155

  De Vries, Helga E ^a,b   Kuiper, Johan ^a   De Boer, Albertus G ^a   Van Berkel, Theo J C ^a   Breimer, Douwe D ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Division of Biopharmaceutics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD18 ANTIGEN; CELL ADHESION MOLECULE; COMPLEMENT FACTOR I; CYTOKINE; FIBRONECTIN; FREE RADICAL; ICOSANOID; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; ANTIGEN EXPRESSION; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; BLOOD GROUP LEWIS SYSTEM; BRAIN EDEMA; BRAIN ISCHEMIA; DRUG TRANSPORT; ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDIATOR; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION MEDIATORS; MENINGITIS, BACTERIAL; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES;

EID: 0030791228     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (146)

1. ADAMS, R. D., AND VICTOR, M.: Multiple sclerosis and allied demyelinative diseases. In Principles of Neurology, pp. 755-768, Mcgraw-Hill Information Services Company, New York, 1989.
2. ANDERSSON, P. B., PERRY, V. H., AND GORDON, S.: The acute inflammatory response to lipopolysaccharide in central nervous system parenchyma differs from that in other body tissues. Neuroscience 48: 169-186, 1992.
3. BABA, T., CHIO, C.-C., AND BLACK, K. L.: The effect of 5-lipoxygenase inhibition on blood-brain barrier permeability in experimental brain tumors. J. Neurosurg. 77: 403-406, 1992.
4. BANKS, W. A., ORTIZ, L., PLOTKIN, S. R., AND KASTIN, A. J.: Human interleukin (IL) 1α, murine interleukin-1α and murine interleukin-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 259: 988-996, 1991.
5. BARANCZYK-KUZMA, A., AUDUS, K. L., AND BORCHARDT, R. T.: Catecholamine-metabolizing enzymes of bovine brain microvessel endothelial cell monolayers. J. Neurochem. 46: 1956-1960, 1986.
6. BARRAND, M. A., ROBERTSON, K. J., NEO, S. Y, RHODES, T., WRIDHT, K. A., TWENTYMAN, P. R., AND SCHEPER, R. J.: Localisation of the multidrug resistance-associated protein, MRP, in resistant large-cell lung tumour cells. Biochem. Pharmacol. 50: 1725-1729, 1995.
7. BARRAND, M. A., ROBERTSON, K. J., AND VON WEIKERSTHAL, S. F.: The comparisons of P-glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epidymal fat pad and from aorta. FEBS Lett. 374: 179-183, 1995.
8. BETZ, A. L., AND GOLDSTEIN, G. W.: Brain capillaries: structure and function. Handbook Neurochem. 7: 465-484, 1984.
9. BEUTLER B., AND CERAMI A.: The biology of cachectin-tumor necrosis factor: a primary mediator of the host response. Ann. Rev. Immunol. 7: 625-655, 1988.
10. BORST, P., AND SCHINKEL, A. H.: Mice with disrupted P-glycoprotein genes. In Multidrug Resistance in Cancer Cells., ed. by S. Gupta and T. Tsuruo, John Wiley & Sons, Ltd., Chischester, Sussex, 1996.
11. BRADBURY, M. W. B.: The blood-brain barrier: transport across the cerebral endothelium. Circ. Res. 57: 213-222, 1985.
12. BRIGHTMAN, M. W., AND REESE, T. S.: Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell. Biol. 40: 648-677, 1969.
13. BROADWELL, R. D., BALIN, B. J., AND SALCMAN, M.: Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc. Natl. Acad. Sci. USA 85: 632-636, 1988.
14. BROADWELL, R. D., AND SALCMAN, M.: Expanding the definition of the blood-brain barrier to protein. Proc. Natl. Acad. Sci. USA 78: 7820-7824, 1981.
15. BUTT, A. M., JONES, H. C., AND ABBOTT, N. J.: Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J. Physiol. 429: 47-62, 1990.
16. CANNELLA, B., CROSS, A. H., AND RAINE, C. S.: Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J. Exp. Med. 172: 1521-1524, 1990.
17. CERVOS-NAVARRO, J., KANNUKI, S., AND NAKAGAWA, Y.: Blood-brain barrier (BBB) review from morphological aspect. Histol. Histopath. 3: 203-213, 1988.
18. CHAN, P. H., YANG, G. Y., CHEN, S. F., CARLSON, E., AND EPSTEIN, C. J.: Cold-induced brain edema and infarction are reduced in transgenic mice over expressing CuZn-superoxide dismutase. Ann. Neurol. 29: 482-486, 1991.
19. CHAN, P. H., SCHMIDLEY, J. W., FISHMAN, R. A., AND LONGAR, S. M.: Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology 34: 315-320, 1984.
20. CLAUDIO L.: Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's patients. Acta Neuropathol. 91: 6-14, 1996.
21. CLAUDIO, L., KRESS, Y., NORTON, W. T., AND BROSNAN, C. F.: Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis. Am. J. Pathol. 135: 1157-1168, 1989.
22. CLAUDIO, L., RAINE, C. S., AND BROSNAN, C. F.: Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol. 90: 228-238, 1995.
23. CORDON-CARDO, C., O'BRIEN, J. P. O., CASALS, D., RITTMAN-GRAUER, L., BIEDLER, J. L., MELAMED, M. R., AND BERTINO, J. R.: Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 86: 695-698, 1989.
24. CRAS, P., KAWAI, M., SIEDLAK, S., MULVIHILL, P., GAMBETTI, P., LOWERY, D., GONZALEZ-DEWHITT, P., AND GREENBERG, G.: Neuronal and microglial involvement in β-amyloid protein disposition in Alzheimer's disease. Am. J. Pathol. 137: 241-246, 1990.
25. DANIEL, P. M., LAM, D. K. C., AND PRATT, O. E.: Relation between the increase in the diffusional permeability of the blood-central nervous system barrier and other changes during the development of experimental allergic encephalomyelitis in the Lewis rat. J. Neurol. Sci. 60: 367-376, 1983.
26. 2 into the central nervous system from the blood. Pharmacology 66: 565-572, 1979.
27. DELI, M. A., DESCAMPS, L., DEHOUCK, M. P., CECCHELLI, R., JOÓ, F., ABRAHAM, C. S., AND TORPIER, G.: Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J. Neurosci. Res. 41: 717-726, 1996.
28. DEMPSEY, E. W., AND WISLOCKI, G. B.: An electron microscopic study of the blood-brain barrier in the rat, employing silver nitrate as a vital stain. J. Biophys. Biochem. Cytol. 1: 245-256, 1955.
29. DE VRIES, H. E., BLOM-ROOSEMALEN, M. C. M., VAN OOSTEN, M., DE BOER, A. G., VAN BERKEL, T. J. C., BREIMER D. D., AND KUIPER J.: The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64: 37-43, 1996.
30. DE VRIES, H. E., HOOGENDOORN, K. H., VAN DUK, J., ZIJLSTRA, F. J., VAN DAM, A. M., BREIMER, D. D., VAN BERKEL, T. J. C., DE BOER, A. G., AND KUIPER, J.: Eicosanoid production by rat cerebral endothelial cells: stimulation by lipopolysaccharide, interleukin-1, and interleukin-6. J. Neuroimmunol. 59: 1-8, 1995.
31. DE VRIES, H. E., MOOR, A. C. E., BLOM-ROOSEMALEN, M. C. M., DE BOER, A. G., BREIMER, D. D., VAN BERKEL, T. J. C., AND KUIPER, J.: Lymphocyte adhesion to brain capillary endothelial cells in vitro. J. Neuroimmunol. 52: 1-8, 1994.
32. EHRLICH, P.: Das Sauerstoffbeduerfnis des Organismus: Eine Farbenanalytiche Studie, vol. 8, p. 167, Hirschwald, Berlin, 1885.
33. ERICSSON, A., LIU, C., HART, R. P., AND SAWCHENKO, P. E.: Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1 induced cellular activity. J. Comp. Neurol. 361: 681-698, 1995.
34. FABRY, Z., WALDSCHMIDT, M. M., HENDRICKSON, D., KEINER, J., LOVE-HOMAN, L., TAKEI, F., AND HART, M. N.: Adhesion molecules on murine brain microvascular endothelial cells: expression of ICAM-1 and Lgp 55. J. Neuroimmunol. 36: 1-11, 1992.
35. FARRELL, C. L., AND PAEDRIDGE, W. M.: Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc. Natl. Acad. Sci. USA 88: 5779-5783, 1991.
36. FEINSTEIN, D. L., GALEA, E., ROBERTS, S., BERQUIST, H., WANG, H., AND REIS, D. J.: Induction of nitric oxide synthetase in rat C6 glioma cells. J. Neurochem. 62: 315-321, 1994.
37. FISHMAN, R. A., AND CHAN, P. H.: Metabolic basis of brain edema. Adv. Neurol. 28: 207-215, 1980.
38. FORD, J. M.: Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitizers. Eur. J. Cancer 32A: 991-1001, 1996.
39. GALLO, P., PICCINO, M. G., PAGNI, S., ARGENTIERO, V., GIOMETTI, B., BOZZA, F., AND TAVOLATO, B.: Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and γ-IFN levels in serum and cerebral spinal fluid. J. Neurol. Sci. 92: 9-15, 1989.
40. GAY, D., AND ESIRI, M.: Blood-brain barrier damage in acute multiple sclerosis. Brain 114: 557-572, 1991.
41. GIJBELS, K., VAN DAMME, J., PROOST, P., PUT, W., CARTON, H., AND BILLIAU, A.: Interleukin-6 production in the central nervous system during EAE. Eur. J. Immunol. 20: 233-235, 1990.
42. GLENNER, G. G., AND WONG, C. W.: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890, 1984.
43. GOLDMANN, E. E.: Die aussere and innere Sekretion des gesundes und kranken Organismus im Lichte der vitalen Farbung. Beitr. Klin. Chir. 64: 192-265, 1909.
44. GOTTESMAN, M. M.: How cancer cells evade chemotherapy: sixteenth Richard and Hindo Rosenthal Foundation Award Lecture. Cancer Res. 53: 747-754, 1993.
45. GRAEBER, M. B., STREIT, W. J., AND KREUTZBERG, G. W.: Identity of ED-2 positive perivascular cells in rat brain. J. Neurosci. Res. 22: 103-106, 1989.
46. GRAMMAS, P., MOORE, P., BOTCHELET, T., HANSON-PAINTON, O., COOPER, D. R., BALL, M. J., AND ROHER, A.: Cerebral microvessels in Alzheimer's have reduced protein kinase C activity. Neurobiol. Aging 4: 563-569, 1995.
47. GRIFFIN D. E., WESSELINGH, S. L., AND MCARTHUR, J. C.: Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 135: 591-597, 1994.
48. GRIOT, C., VANDEVELDE, M., RICHARD, A., PETERHANS, E., AND STOCKER, R.: Selective degeneration of oligodendrocytes mediated by oxygen radical species. Free Radical Res. Commun. 11: 181-193, 1990.
49. GULEVICH, S. J., AND WILEY, C. A.: HIV infection and the brain. AIDS 5: S49-S54, 1991.
50. HAFLER, D. A., AND WEINER, H. L.: T-cells in multiple sclerosis and inflammatory central nervous system diseases. Immunol. Rev. 100: 307-332, 1987.
51. HARIK, S. I.: Changes in the glucose transporter of brain capillaries. Can. J. Physiol. Pharmacol. 70(suppl): S113-S117, 1992.
52. HARTUNG, H. P., MICHELS, M., REINERS, K., SEELDRAYERS, P., ARCHELOS, J. J., AND TOYKA, K. V.: Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis. Neurology 43: 2331-2335, 1993.
53. HASHIMOTO, P. H.: Aspects of normal cerebrospinal fluid circulation and circumventricular organs. Prog. Brain Res. 91: 439-443, 1992.
54. HASHIMOTO, M., ISHIKAWA, Y., GOTO, F., BANDO, T., SAKAKIBARA, Y., AND IRIKI, M.: Action site of circulating interleukin-1 on the rabbit brain. Brain Res. 540: 217-223, 1991.
55. HAWKINS, C. P., MACKENZIE, F., TOFTS, P., DU BOULAY, E. P. G. H., AND MCDONALD, W. I.: Expanding the definition of the blood-brain barrier to protein. Brain 114: 801-810, 1991.
56. HEGMANN, E. J., BAUER, H. C., AND KERBEL, S.: Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res. 52: 6969-6975, 1992.
57. HEIMARK, R. L.: Cell-cell adhesion of molecules the blood-brain barrier. In The Blood-brain Barrier: Cellular and Molecular Biology, ed. by W. M. Pardridge, pp. 88-106, Lippincott-Raven, New York, 1993.
58. HIGGINS, C. F., HILES, I. D., SALMONEL, G. P. C., GILL, D. R., DOWNIE, J. A., EVANS, I. J., HOLLAND, I. B., GRAY, L., BUCKEL, S. D., BELL, A. W., AND HERMODSON, M. A.: A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature (Lond.) 323: 448-450, 1986.
59. HURWITZ, A. A., BERMAN, J. W., AND LYMAN, W. D.: The role of the blood-brain barrier in HIV infection of the central nervous system. Adv. Neuroimmunol. 4: 249-256, 1994.
60. HUYNH, H. K., AND DOROVINI-ZIS, K.: Effects of interferon-γ on primary cultures of human brain microvessel endothelial cells. Am. J. Pathol. 142: 1265-1278, 1993.
61. IKEDA, Y., ANDERSON, J. H., AND LONG, D. M.: Oxygen free radicals in the genesis of traumatic and peritumoral brain edema. Neurosurgery 24: 679-685, 1989.
62. JACOBS, R. F., AND TABOR, D. R.: The immunology of sepsis and meningitiscytokine biology. Scand. J. Infect. Dis. Suppl. 73: 7-15, 1990.
63. JEDLITSCHKY, G., LEIER, I., BUCHHOLZ, U., BARNOUIN, K., KURZ, G., AND KEPPLER, D.: Transport of glutathione. glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56: 988-994, 1996.
64. JOÓ, F.: The role of endothelial second messenger's-generating system in the pathogenesis of brain oedema. Acta Neurochir. Suppl. 51: 195-197, 1990.
65. JOÓ, F., AND KLATZO, I.: Role of cerebral endothelium in brain oedema. Neurol. Res. 11: 67-75, 1989.
66. JUHLER, M.: Pathophysiological aspects of acute experimental allergic encephalomyelitis. Acta Neurol. Scand. Suppl. 119: 3-21, 1988.
67. JUHLER, M., BLASBERG, R. G., FENSTERMACHER, J. D., PATLAK, C. S., AND PAULSON, O. B.: A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis. J. Cereb. Blood Flow Metab. 5: 545-553, 1985.
68. KALARIA, R. N.: The blood-brain barrier and cerebral microcirculation in Alzheimer's disease. Cerebrovasc. Brain Metab. Rev. 4: 226-260, 1992.
69. KALARIA, R. N., AND HARK, S. I.: Blood-brain barrier monoamino-oxidase: enzyme characterization in cerebral microvessels and other tissues from six mammalian species, including human. J. Neurochem. 49: 856-864, 1987.
70. KALARIA, R. N., AND PAX, A. B.: Increased collagen content of cerebral mi-crovessels in Alzheimer's disease. Brain Res. 705: 349-352, 1995.
71. KIM, Y. S., AND KIM, S. U.: Oligodendroglial cell death induced by oxygen radicals and its protection by catalase. J. Neurosci. 29: 100-106, 1991.
72. KIM, K. S., WASS, C. A., CROSS, A. S., AND OPAL, S. M.: Modulation of blood-brain barrier permeability by tumor necrosis factor α in the rat. Lymphokine Cytokine Res. 11: 293-298, 1992.
73. KLATZO, I.: Presidential address: neuropathological aspects of brain edema. J. Neuropathol. Exp. Neurol. 26: 1-14, 1967.
74. KLATZO, I.: Pathophysiological aspects of brain edema. Acta. Neuropathol. 72: 236-239, 1987.
75. KOH, C., GAUSAS, J., AND PATERSON, P. Y.: Concordance and localization of maximal vascular permeability change and fibrin disposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis. J. Neuroimmunol. 38: 85-94, 1992.
76. KOIDE, T., ASANO, T., MATSUSHITA, H., AND TAKAKURA, K.: Enhancement of ATPase activity by a lipid peroxide of arachidonic acid in rat brain microvessels. J. Neurochem. 46: 235-242, 1986.
77. KWON, E. E., AND PRINEAS, J. W.: Blood-brain barrier abnormalities in long-standing multiple sclerosis lesions: an immunohistochemical study. J. Neuropathol. Exp. Neurol. 53: 625-636, 1994.
78. LASSMANN, H., ZIMPRICH, F., RöSSLER, K., AND VASS, K.: Mise au point: inflammation in the nervous system. Rev. Neurol. 147: 763-781, 1991.
79. LENHARDT, T. M., AND WILEY, C. A.: Absence of humorally mediated damage within the central nervous system of AIDS patients. Neurology 39: 278-280, 1989.
80. LEVEQUE, D., AND JEHL, F.: P-glycoprotein and pharmacokinetics. Anticancer Res. 15: 331-336, 1995.
81. LIUZZI, G. M., MASTROIANNI, C. M., VULLO, V., JIRILLO, E., DELIA, S., AND RICCIO, P.: Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex. J. Neuroimmunol. 36: 251-254, 1992.
82. MALE, D., PRYCE, G. LINKE, A., AND RAHMAN, J.: Lymphocyte migration into the CNS modelled in vitro. J. Neuroimmunol. 40: 167-172, 1992.
83. MAROTTA, C. A., MAJOCHA, R. E., AND TATE, B.: Molecular and cellular biology of Alzheimer amyloid. J. Mol. Neurosci. 3: 111-125, 1992.
84. MASTERS, C. L., SIMMS, G., WEINMANN, N. A., MULTHAUP, G., MCDONALD, B. L., AND BEYREUTHER, K.: Amyloid plaque core protein in Alzheimer disease and Down's syndrome. Proc. Natl. Acad. Sci. USA 82: 4245-4249, 1985.
85. MATTILA, K. M., PIRTILÄ, T., BLENNOW, K., WALLIN, A., VITANEN, M., AND FREY, H.: Altered blood-brain barrier function in Alzheimer's disease? Acta Neurol. Scand. 89: 192-198, 1994.
86. MAXWELL, K. M., BERLINER, J. A., AND CANCILLA, P. A.: Induction of γ-glutamyl transpeptidase in cultured cerebral endothelial cells by a product released by astrocytes. Brain Res. 410: 309-314, 1987.
87. MAYER, U., WAGENAAR, E., BEIJNEN, J. H., SMIT, J. W., MEYER, D. K. F., VAN ASPEREN, J., BORST, P., AND SCHINKEL, A. H.: Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr1a-P-glycoprotein. Br. J. Pharmacol. 119: 1038-1044, 1996.
88. MECOCCI, P., PARNETTI, L., REBOLDI, G. P., SANTUCCI, C., GAITI, A., FERRI, C., GERNINI, I., ROMAGNOLI, M., CADINI, D., AND SENIN, U.: Blood-brain barrier in geriatric population: barrier function in degenerative and vascular dementias. Acta Neurol. Scand. 84: 210-213, 1991.
89. MEGYERI, P., ABRAHAM, C. S., TEMESVARI, P., KOVACS, J., VAS, T., AND SPEER, C. P.: Recombinant human tumor necrosis factor a constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci. Lett. 148: 137-140, 1992.
90. MICHIELS, C., ARNOULD, T., KNOTT, I., DIEU, M., AND REMACLE, J.: Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. Am. J. Physiol. 264: C866-C874, 1993.
91. 2. In The Pharmacological Basis of Therapeutics, ed. by A. G. Gilman, L. S. Goodman, T. W. Rall, and F. Murad, pp. 660-673, Macmillan Publishing, New York, 1985.
92. MOOR, A. C. E., DE VRIES, H. E., DE BOER, A. G., AND BREIMER, D. D.: The blood-brain barrier and multiple sclerosis. Biochem. Pharmaeol. 47: 1717-1724, 1994.
93. MOORE, S. A., SPECTOR, A. A., AND HART, M. N.: Eicosanoid metabolism in cerebromicrovascular endothelium. Am. J. Physiol. 254: C37-C44, 1988.
94. MORGANTI-KOSSMANN, M. C., KOSSMANN, T., AND WAHL, S. M.: Cytokines and neuropathology. Trends Pharmaeol. Sci. 13: 286-291, 1992.
95. MORIN, A. M., AND STANBOLI, A.: Nitric oxide localization in cultured cerebrovascular endothelium during mitosis. Exp. Cell Res. 211: 183-188, 1994.
96. MOSES, A. V., AND NELSON, J. A.: HIV infection of human brain capillary endothelial cells: implications for AIDS dementia. Adv. Neuroimmunol. 4: 239-247, 1994.
97. ω-nitro-L-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats. Neurosci. Lett. 147: 159-162, 1992.
98. NAVIA, B. A., CHO, E. S., AND PRICE, R. W.: The AIDS dementia complex: II. Neuropathology. Ann. Neurol. 19: 525-535, 1986.
99. NELSON, C. W., WEI, E. P., POVLISHOCK, J. T., KONTOS, H. A., AND MOSKOWITZ, M. A.: Oxygen radicals in cerebral ischemia. Am. J. Physiol. 263: H1356-H1362, 1992.
100. NOTTET, H. S., PERSIDSKY, Y., SASSEVILLE, V. G., NUKUNA, A. N., BOCK, P., ZHAI, Q. H., SHARER, L. R., MCCOMB, R. D., SWINDELLS, S., SODERLAND, C., AND GENDELMAN, H. E.: Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 56: 1284-1295, 1996.
101. OSBORN, L.: Leucocyte adhesion to endothelium in inflammation. Cell 62: 3-6, 1990.
102. PARDRIDGE, W. M.: Blood-brain barrier transport of nutrients. Fed. Proc. 45: 2047-2049, 1986.
103. PFISTER, H. W., KOEDEL, U., DIRNAGL, U., HABERL, R. L., FEIDEN, W., AND EINHÄUPL, K. M.: Superoxide dismutase inhibits brain oedema formation in experimental pneumococcal meningitis. Acta Neurochir. Suppl. 51: 378-380, 1990.
104. PIPER, P. J., AND SAMHOUN, M. N.: Leukotrienes. Br. Med. Bull. 43: 297-311, 1987.
105. PLATA-SALAMÁN, C. R.: Immunoregulators in the nervous system. Neurosci. Biobehav. Rev. 15: 185-215, 1991.
106. PLUTA, R., LOSSINSKY, A. S., WISNIEWSKI, H. M., AND MOSSAKOWSKI, M. J.: Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest. Brain Res. 633: 41-52, 1994.
107. POSER, C. M.: The pathogenesis of multiple sclerosis: additional considerations. J. Neurol. Sci. 115: 3-15, 1993.
108. PRESTON, E., SUTHERLAND, G., AND FINSTEN, A.: Three openings in the blood-brain barrier produced by forebrain ischemia in the rat. Neurosci. Lett. 149: 75-78, 1993.
109. QUAGLIARELLO, V. J., WISPELWEY, B., LONG, W. J., AND SCHELD, W. M.: Recombinant human interleukin-1 induces meningitis and BBB injury in the rat. J. Clin. Invest. 87: 1360-1366, 1991.
110. RAINE, C. S., LEE, S. C., SCHEINBERG, L. C., DUIJVESTIJN, A. M., AND CROSS, A. H.: Short analytical review: adhesion molecules on endothelial cells in the central nervous system. An emerging area in the neuroimmunology of multiple sclerosis. Clin Immunol. Immunopathol. 57: 173-187, 1990.
111. RAPOPORT, S. I., OHNO, K., AND PETTIGREW, K. D.: Drug entry into the brain. Brain Res. 172: 354-359, 1979.
112. REESE, T. S., AND KARNOVSKY, M. J.: Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell. Biol. 34: 207-217, 1967.
113. RHODES, R. H.: Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J. Neuropathol. Exp. Neurol. 50: 171-183, 1991.
114. SAEED ABDEL-HALIM, M., VON HOLST, H., MEYERSON, B., SACHS, C., AND ANGGARD, E.: Prostaglandin profiles in tissue and blood vessels from human brain. J. Neurochem. 34: 1331-1333, 1980.
115. SAID, S., ROSENBLUM, W. I., POVLISHOCK, J. T., AND NELSON, G. H.: Correlations between morphological changes in platelet aggregates and underlying endothelial damage in cerebral microcirculation of mice. Stroke 24: 1968-1974, 1993.
116. SASSEVILLE, V. G., NEWMAN, W. A., LACKNER, A. A., SMITH, M. O., LAUSEN, N. C. G., BEAL, D., AND RINGLER, J. D.: Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am. J. Pathol. 141: 1021-1030, 1992.
117. SCHINKEL, A. H., SMIT, J. J. M., VAN TELLINGEN, O., BEIJNEN, J. H., WAGENAAR, E., VAN DEEMTER, L., MOL, C. A. A. M., VAN DER VALK, M. A., ROBANUS-MAANDAG, E. C., TE RIELE, H. P. J., BERNS, A. J. M., AND BORST, P.: Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood brain barrier and to increased sensitivity to drugs. Cell 77: 491-502, 1995a.
118. SCHINKEL, A. H., WAGENAAR, E., MOL, C. A. A. M., AND VAN DEEMTER, L.: P-glycoprotein in the blood-brain barrier controls the brain penetration and thus the clinical use of many drugs. J. Clin. Invest. 96: 1698-1705, 1995b.
119. SHARIEF, M. K., HENTGES, R., CIARDI, M., AND THOMPSON, E. J.: In vivo relationship of interleukin-2 and soluble IL-2 receptor in blood-brain barrier impairment in patients with active multiple sclerosis. J. Neurol. 240:46-50, 1993a.
120. SHARIEF, M. K., NOORI, M. A., CIRELLI, A., AND THOMPSON, E. J.: Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis: correlation with tumor necrosis factor-α and blood-brain barrier damage. J. Neuroimmunol. 43: 15-22, 1993b.
121. SHAW, C. E., DUNBAR, P. R., MACAULEY, H. A., AND NEALE, T. J.: Measurement of immune markers and cerebrospinal fluid of multiple sclerosis patients during clinical remission. J. Neurol. 242: 53-58, 1995.
122. SHIMIZU, T., AND WOLFE, L. S.: Arachidonic acid cascade and signal transduction. J. Neurochem. 55: 1-15, 1990.
123. SHUKLA, A., DIKSHIT, M., AND SRIMAL, R. C.: Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium. Neuroreport 6: 1629-1632, 1995.
124. SMIT, J. J., SCHINKEL, A. H., OUDE-ELFERINK, R. P., GROEN, A. K., WAGENAAR, E., VAN-DEEMTER, L., MOL, C. A., OTTENHOFF, R., VAN-DER-LUGT, N. M., AND VAN-ROON, M. A.: Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75: 451-462, 1993.
125. SPECTOR, R.: Drug transport in the central nervous system: role of carriers. Pharmacology 40: 1-7, 1990.
126. SPRINGER, T. A.: Adhesion receptors of the immune system. Nature (Lond.) 346: 425-434, 1990.
127. STEWART, P. A., HAYAKAWA, K., AKERS, M. A., AND VINTERS, H. V.: A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab. Invest. 67: 734-742, 1992.
128. STRUBLE, R. G., PRICE, D. L., AND CORK, L. C.: Senile plaque in cortex of aged normal monkeys. Brain Res. 361: 267-275, 1985.
129. TANNO, H., NOCKELS, R. P., PITTS, L. H., AND NOBLE, L. J.: Breakdown of the blood-brain barrier after fluid percussion brain injury in the rat. J. Neurotrauma. 9: 335-347, 1992.
130. THIEBAUT, F., TSURUO, T., HAMADA, H., GOTTESMAN, M. M., PASTAN, I., AND WILLINGHAM, M. C.: Cellular localization of the multidrug resistance gene product in normal human tissues. Proc. Natl. Acad. Sci. USA 84: 7735-7738, 1987.
131. TUNKEL, A. R., AND SCHELD, W. M.: Pathogenesis and pathophysiology of bacterial meningitis. Annu. Rev. Med. 44: 103-120, 1993.
132. TUOMANEN, E.: Breaching the blood-brain barrier. Sci. Am. 268: 56-60, 1993.
133. TUOMANEN, E. I., LIU, H., HENGSTLER, B., ZAK, O., AND TOMASZ, A.: The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151: 859-868, 1985.
134. VAN BREE, J. B. M. M., DE BOER, A. G., DANHOF, M., GINSEL, L. A., AND BREIMER, D. D.: Characterization of an in vitro blood-brain barrier (BBB): effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. J. Pharmacol. Exp. Ther. 247: 1233-1239, 1988.
135. VAN DAM, A. M., DE VRIES, H. E., KUIPER, J., ZIJLSTRA, F. J., DE BOER, A. G., TILDERS, F. J. H., AND BERKENBOSCH, F.: Interleukin-1 receptors on rat brain endothelial cells: a role in neuro-immune interaction? FASEB J. 10: 351-356, 1996.
136. VERBEEK, M. M., OTTE-HÖLLER, I., WESTPHAL, J. R., WESSELING, P., RUITER, D. J., AND DE WAAL, R. M. W.: Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease. Am. J. Pathol. 144: 104-116, 1994.
137. VINTERS, H. V., LENARD SECOR, D., READ, S. L., FRAZEE, J. G., TOMIYASU, U., STANLEY, T. M., FERREIRO, J. A., AND AKERS, M. A.: Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. Ultrastruct. Pathol. 18: 333-348, 1994.
138. VINTERS, H. V., NISHIMURA, G. S., SECOR, D. L., AND PARDRIDGE, W. M.: Immunoreactive A4 and gamma-trace peptide colocalization in amyloiditic arteriolar lesions in brains of patients with Alzheimer's disease. Am. J. Pathol. 137: 233-240, 1990.
139. WAHL, M., UNTERBERG, A., BAETHMANN, A., AND SCHILLING, L.: Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J. Cereb. Blood Flow Metab. 8: 621-634, 1988.
140. WASHINGTON R., BURTON, J., TODD, R. F., NEWMAN, W., DRAGOVIC, L., AND DORE-DUFFY, P.: Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann. Neurol. 35: 89-97, 1994.
141. WEKERLE, H., LININGTON, C., LASSMANN, H., AND MEYERMANN, R.: Cellular immune reactivity within the CNS. Trends Neurol. Sci. 9: 271-277, 1986.
142. WELLS, J. M., AMARATUNGA, A., MCKENNA, D. C., ABRAHAM, C. R., AND FINE, R. E.: Amyloid β-protein precursor and apolipoprotein E production in cultured cerebral endothelial cells isolated from brains of patients with neurodegenerative disorders at autopsy: amyloid. Int. J. Exp. Clin. Invest. 2: 229-233, 1995.
143. WESTERGAARD, E.: Ultrastructural permeability properties of cerebral microvasculature under normal and experimental conditions after application of tracers. Adv. Neurol. 28: 55-74, 1980.
144. WILCOX, C. E., WARD, A. M. V., EVANS, A., BAKER, D., ROTHLEIN, R., AND TURK, J. L.: Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 30: 43-51, 1990.
145. WISPELWEY, B., LESSE, A. J., HANSEN, E. J., AND SCHELD, W. M.: Haemophilus influenzas lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J. Clin. Invest. 82: 1339-1346, 1988.
146. 1 integrin (VLA-4). Nature (Lond.) 356: 63-66, 1992.